NCT00002723 arm group c97531b8dc49afe3f4cf3bf50d503f8c [clinicaltrials_resource:NCT00002723/arm-group/c97531b8dc49afe3f4cf3bf50d503f8c]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00002723 arm group c97531b8dc49afe3f4cf3bf50d503f8c [clinicaltrials_resource:NCT00002723/arm-group/c97531b8dc49afe3f4cf3bf50d503f8c]
Bio2RDF identifier
NCT00002723/arm-group/c97531b8dc49afe3f4cf3bf50d503f8c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 7531b8dc49afe3f4cf3bf50d503f8c
description [clinicaltrials_vocabulary:description]
Intermediate dose suramin
identifier
clinicaltrials_resource:NCT00002723/arm-group/c97531b8dc49afe3f4cf3bf50d503f8c
title
NCT00002723 arm group c97531b8dc49afe3f4cf3bf50d503f8c
@en
type
label
NCT00002723 arm group c97531b8 ...... 531b8dc49afe3f4cf3bf50d503f8c]
@en